Bristol-Myers Squibb suffers at hands of generic Plavix
October 26, 2006Sales and Marketing
Figures show that the launch of a generic competitor to Plavix in the US dealt a serious blow to Bristol-Myers …
Takeda launches Actos combination in UK
October 26, 2006Sales and Marketing
Takeda has expanded its type II diabetes portfolio in the UK with the launch of Competact, a combination of the …
Cerovive failure another blow for AstraZeneca
October 26, 2006Research and Development, Sales and Marketing AstraZeneca, Cerovive, neuroscience
A drug which had held out the promise of reducing the disabling effects of stroke on patients will be abandoned …
Lilly underlines its position as major biotech company
October 25, 2006Research and Development
Eli Lilly has opened the first phase of a $560 million expansion to its US biotech research complex.The news comes …
Freedom to Prescribe v The Formulary
October 24, 2006GP, NHS, doctors, healthcare
The modern concept of a formulary embraces three basic principles: first, it is a limited list of treatments chosen from …
EU recommends first ever therapy for Hunter syndrome
October 24, 2006Sales and Marketing
Shire has received full EU recommendation for the use of Elaprase for the long-term treatment of patients with Hunter syndrome.Marketing …
Industry calls for global healthcare systems to be benchmarked
October 13, 2006Sales and Marketing
Fred Hassan, chief executive of Schering-Plough and new head of an international pharma industry organisation, has called for greater transparency …
New schizophrenia treatment promises no weight gain side-effects
October 13, 2006Sales and Marketing
Solvay and Wyeth have filed a new treatment for schizophrenia with the US regulators, which promises to be free of …
Watchdog urges NHS to ‘raise its game’
October 12, 2006An NHS watchdog has told managers the health service must raise its game following a national review of performance revealed …
From surgery to pharmacy
October 12, 2006Sales and Marketing P, POM, marketing, reclassification, sales
Pfizer buys British vaccine company PowderMed
October 12, 2006Research and Development Pfizer, Powdermed, vaccines
Pfizer will gain entry into the fast-growing vaccines market by buying PowderMed, the British company developing next generation products in …
Alzheimer’s drug ruling ”a terrible decision”
October 11, 2006Sales and Marketing
Campaigners are stunned at NICE's final decision not to allow Alzheimer's drugs to be prescribed on the NHS in the …
Takeda retains The Remedy for European events
October 6, 2006Medical Communications
Takeda Europe has re-appointed marketing firm The Remedy to run its pan-European and international meetings for 2007.The Remedy, which is …
Amgen to acquire Avidia
October 5, 2006Research and Development, Sales and Marketing
Amgen is to pay $290 million to buy Avidia, a Californian biotech company which is developing innovative new protein-based medicines.Based …
General practice reaps rewards of contract
October 2, 2006GPs and patients are continuing to reap the rewards of the new general practice contract, with doctors hitting targets for …
Novartis’ MS drug shows further promise
October 2, 2006Research and Development
A new treatment for multiple sclerosis currently being developed by Novartis has shown further promise in slowing the progress of …
Transparently beneficial?
October 2, 2006Medical Communications, Sales and Marketing industry relations, key opinion leaders, pharma
The pharma industry is under greater pressure than ever before to adopt an acceptable and ethical way of doing business, …
Pharmacists unhappy with Pfizer’s new UK supply chain
September 29, 2006Manufacturing and Production
Pfizer has announced a radical overhaul of how it distributes its medicines to community pharmacists and dispensing doctors in the …
Novartis submits next generation blood pressure drug
September 29, 2006Sales and Marketing
Next generation hypertension drug Rasilez has been submitted for EU approval.If approved, Rasilez will be the first ever renin inhibitor, …
Two new AstraZeneca laboratories opened in UK
September 29, 2006Research and Development
AstraZeneca has officially opened two major research laboratories in the UK, which it says demonstrates its commitment to R&D in …
Latest content
FibroFind appoints Lee Borthwick as CEO
